Abstract: To accurately generate the three-dimensional ultrasound data and/or determine the position of the ultrasound scan relative to pre-operative data, a tracking sensor is releasably connected with the ultrasound probe. The connection positions the tracking sensor near a distal end of the probe for insertion into the patient. A needle guide may be similarly releasably connected with the probe and, at least in part, inserted into the patient.

Abstract: To accurately generate the three-dimensional ultrasound data and/or determine the position of the ultrasound scan relative to pre-operative data, a tracking sensor is releasably connected with the ultrasound probe. The connection positions the tracking sensor near a distal end of the probe for insertion into the patient. A needle guide may be similarly releasably connected with the probe and, at least in part, inserted into the patient.

Abstract: Scan timing of contrast agent study is provided. Ultrasound is used to determine timing of contrast agent inflow and/or outflow. The timing based on the ultrasound scanning controls scanning for MR or CT imaging. The MR or CT contrast agent imaging for MR or CT contrast agents may be synchronized using the ultrasound contrast agent flow.

Abstract: Magnetic resonance and ultrasound parametric image is fused or combined. MRI and ultrasound imaging are used to acquire the same type of parametric images. Fused data is created by combining ultrasound and MRI parametric data at times for which both types of data are available. Rather than sacrificing rate, fused data is created for times for which MRI data is not acquired. A curve representing the values of the parameter over time is fit to the available MRI and ultrasound data of each location, resulting in fused data at times for which MRI data is not available.

Abstract: Magnetic resonance imaging frame rate is increased using ultrasound information. Magnetic resonance (MR) images may be provided at an increased frame rate relative to the MR acquisition. For times between acquisition of MR data, MR data may be created. To account for any change in position of tissue over time, ultrasound is used to track the location of tissue or other imaged structure. The ultrasound-based location information is used to indicate the position of intensities or values of the created MR data. MR images at a higher frame rate than the MR acquisition are generated, but with accuracy of relative position based on the ultrasound data.

Abstract: Therapy control and/or monitoring is performed with an ultrasound scanner. The ultrasound scanner detects temperature to monitor therapy, and perform HIFU beam location refocusing of the therapy system based on the temperature. The monitoring is synchronized with the therapy using a trigger output of the ultrasound scanner. The trigger output responds to a scan sequence of the ultrasound scanner. To meet a given therapy plan, the scan sequence is customized, resulting in the customized trigger sequence. Three dimensional or multi-planar reconstruction rendering is used to represent temperature for monitoring feedback. The temperature at locations not being treated may be monitored. If the temperature has an undesired characteristic (e.g., too high), then the therapy is controlled by ceasing, at least temporarily.

Abstract: Scan timing of contrast agent study is provided. Ultrasound is used to determine timing of contrast agent inflow and/or outflow. The timing based on the ultrasound scanning controls scanning for MR or CT imaging. The MR or CT contrast agent imaging for MR or CT contrast agents may be synchronized using the ultrasound contrast agent flow.

Abstract: Magnetic resonance and ultrasound parametric image is fused or combined. MRI and ultrasound imaging are used to acquire the same type of parametric images. Fused data is created by combining ultrasound and MRI parametric data at times for which both types of data are available. Rather than sacrificing rate, fused data is created for times for which MRI data is not acquired. A curve representing the values of the parameter over time is fit to the available MRI and ultrasound data of each location, resulting in fused data at times for which MRI data is not available.

Abstract: A viscoelastic property of tissue is measured in vivo. To collect more information and/or estimate viscosity, shear modulus, and/or other shear characteristics, an amplitude and phase modulated waveform is transmitted to the tissue. The displacement caused by the waveform over time includes displacements associated with response to different frequencies. By examining the displacement in the frequency domain, one or more viscoelastic properties may be calculated for different frequencies. The frequency response may indicate the health of the tissue.

Abstract: A viscoelastic property of tissue is measured in vivo. To collect more information and/or estimate viscosity, shear modulus, and/or other shear characteristics, an amplitude and phase modulated waveform is transmitted to the tissue. The displacement caused by the waveform over time includes displacements associated with response to different frequencies. By examining the displacement in the frequency domain, one or more viscoelastic properties may be calculated for different frequencies. The frequency response may indicate the health of the tissue.